Detalhe da pesquisa
1.
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Eur Respir J
; 47(2): 564-74, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26647431
2.
[The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 34(2): 109-13, 2011 Feb.
Artigo
Chinês
| MEDLINE | ID: mdl-21426728
3.
[The correlation between polymorphisms of genes with susceptibility to tuberculosis and the clinical characteristics of tuberculosis in 459 Han patients].
Zhonghua Jie He He Hu Xi Za Zhi
; 34(12): 923-8, 2011 Dec.
Artigo
Chinês
| MEDLINE | ID: mdl-22333506
4.
Notice of retraction. Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment.
J Antimicrob Chemother
; 69(3): e1, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22396431
5.
[Clinical, pathological and radiological characteristics of 83 cases of pleural tuberculoma].
Zhonghua Jie He He Hu Xi Za Zhi
; 32(4): 262-5, 2009 Apr.
Artigo
Chinês
| MEDLINE | ID: mdl-19576038
6.
Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
Chin Med J (Engl)
; 131(3): 268-275, 2018 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29363640
7.
[Difficulty and confusion about treatment of nontuberculous mycobacterial lung diseases].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(8): 566-8, 2012 Aug.
Artigo
Chinês
| MEDLINE | ID: mdl-23158004
8.
[Recent advances in nontuberculous mycobacterial disease].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(7): 527-31, 2012 Jul.
Artigo
Chinês
| MEDLINE | ID: mdl-22931807
9.
[Several issues on diagnosis and treatment of silicosis and tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 34(8): 568-70, 2011 Aug.
Artigo
Chinês
| MEDLINE | ID: mdl-22168975
10.
[Advances in the study of human genetic polymorphisms in tuberculosis and drug-resistant tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 33(7): 534-6, 2010 Jul.
Artigo
Chinês
| MEDLINE | ID: mdl-20979802
11.
An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.
Int J Clin Exp Med
; 8(3): 4320-7, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26064348
12.
[Advances in the study of extensively drug resistant tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 32(5): 380-3, 2009 May.
Artigo
Chinês
| MEDLINE | ID: mdl-19799076
13.
[Advances in the study of chemotherapy of multidrug-resistant tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 32(8): 617-20, 2009 Aug.
Artigo
Chinês
| MEDLINE | ID: mdl-19958683
14.
[Advances in the study of drugs for the treatment of multi-drug resistant tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 29(8): 567-9, 2006 Aug.
Artigo
Chinês
| MEDLINE | ID: mdl-17074274
15.
[Study on the correlation between polymorphisms of genes with susceptibility to tuberculosis and drug-resistant tuberculosis in Chinese Han population].
Zhonghua Liu Xing Bing Xue Za Zhi
; 32(3): 279-84, 2011 Mar.
Artigo
Chinês
| MEDLINE | ID: mdl-21457666
16.
[Apoptosis and tuberculosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 27(7): 477-9, 2004 Jul.
Artigo
Chinês
| MEDLINE | ID: mdl-15312562